News
16 Sep 2021
Therapeutic targeting for SARS-CoV-2 using CRISPR-Cas13
First published in the Doherty Institute Impact Report 2020
News Archive
For any media enquiries, please contact:
Communications Team
P: +61383441911
E: doherty-media@unimelb.edu.au